(�)-1,1,1-Trifluoro-2-butanamine hydrochloride, 95%, 1g

5-BROMO-2-(1,3-DIOXOLAN-2-YL)-1,3-THIAZOLE, 95.0%, 10g

Ethyl 3-(4-morpholinophenyl)-3-oxopropanoate, 95.0%, 1g

5H-Pyrido[4,3-b]indole, 97.0%, 5g

2-Bromo-4-methylthiazole-5-carbaldehyde, 97%, 10g

Filtration unit Stericup® with Durapore® (PVDF) membrane Pore size 0.45 μm, 500 ml, 500 ml, 12 Piece(s)

1-(4-Fluorophenyl)-5-(thiophen-2-yl)-1h-pyrazole-3-carboxylic acid, 95%, 250mg

2-Bromo-4,5-dimethylphenol, 97.0%, 10g

3,4-Dimethoxy-2-methylbenzaldehyde, 97%, 2.5g

(4S,4'S)-2,2'-(1,3-Bis(4-(tert-butyl)phenyl)propane-2,2-diyl)bis(4-methyl-4,5-dihydrooxazole), 97%, 100mg

2-Methoxy-4-(methylsulfonyl)aniline, 95.0%, 10g

Triphenyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)silane, 98%, 5g

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-Nepsilon-(4-methyltrityl)-L-lysine>98.0%(HPLC)(N)1g